Primary Device ID | 08056771602945 |
NIH Device Record Key | 75ed3b24-1292-41f5-b960-44f71d577242 |
Commercial Distribution Status | In Commercial Distribution |
Brand Name | LIAISON QUANTIferon TB Gold Plus |
Version Model Number | 311020 |
Company DUNS | 033429783 |
Company Name | Diasorin Inc. |
Device Count | 1 |
DM Exempt | false |
Pre-market Exempt | false |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | false |
Device Combination Product | false |
Single Use | false |
Lot Batch | true |
Serial Number | false |
Manufacturing Date | false |
Expiration Date | true |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | false |
OTC Over-The-Counter | false |
Device Issuing Agency | Device ID |
---|---|
GS1 | 08056771602945 [Primary] |
NCD | Test, Immunity, Cell Mediated, Mycobacterium Tuberculosis |
Steralize Prior To Use | false |
Device Is Sterile | false |
Public Version Status | New |
Device Record Status | Published |
Public Version Number | 1 |
Public Version Date | 2023-09-18 |
Device Publish Date | 2023-09-08 |
08056771602945 - LIAISON QUANTIferon TB Gold Plus | 2023-09-18USA manufactured kit |
08056771602945 - LIAISON QUANTIferon TB Gold Plus | 2023-09-18 USA manufactured kit |
08056771602952 - LIAISON Control QUANTIferon TB Gold Plus | 2023-09-18 USA manufactured control kit |
08056771600002 - LIAISON® Testosterone | 2023-05-03 |
08056771600019 - LIAISON® Testosterone Control Set | 2023-05-03 |
08056771602969 - LIAISON MeMed BV | 2022-08-18 The DiaSorin LIAISON MeMed BV is a semi-quantitative assay that uses chemiluminescent immunoassay (CLIA) technology to measure |
08056771602976 - LIAISON MeMed BV Control Set | 2022-08-18 The DiaSorin LIAISON MeMed BV Control Set is intended for use as assayed quality control samples to monitor the performance of t |
08056771602884 - LIAISON Q.S.E.T. Device Plus | 2022-08-17 Fecal extraction device |
08056771600590 - LIAISON Calprotectin | 2022-06-10 |